期刊文献+

人乳头瘤病毒检测在宫颈疾病诊断中的意义 被引量:34

Clinic significance of human papillomavirus detection in diagnosis of precancerous cervical diseases
下载PDF
导出
摘要 目的探讨人乳头瘤病毒(human papillomavirus,HPV)联合宫颈液基细胞学(thin-prep cytol-ogy test,TCT)检测在宫颈病变诊断中的临床意义,以及HPV负荷量与宫颈病变程度的相关性。方法对我院妇科2350名患者行宫颈TCT和高危型HPV检测。结果HPV高危阳性患者共895例,阳性检出率为38.09%,TCT结果正常组内:正常、轻度炎症、中度炎症、重度炎症HPV阳性率分别为17.06%、28.30%、36.43%和30.30%;②TCT结果为正常组、ASCUS、ASC-H、LSIL、HSIL中,HPV阳性率分别为27.60%、52.30%、61.31%、86.11%、91.25%。③将HPV负荷量由低至高行数量分级后,TCT异常率分别为12.92%、25.93%、41.38%、50.52%和65.74%。结论在TCT异常者中,病变程度越高,高危型HPV感染率越高。随着病毒负荷量增加,宫颈病变发生,率增加,其病变程度也越重。 Objective To investigate the clinic significance of ThinPrep Cytology Test (TCT) combined with humanpapilloma virus (HPV) DNA hybrid capture Ⅱ (HC Ⅱ) in diagnosis of cervical diseases. To explore the relationship between viral load of HPV and the grade of cervical lesions. Methods Cervical cytological examination and HPV screening were carried by TCT and HC Ⅱin 2 350 women. Results High risk HPV DNA was detected in 895 cases (38.09%). The HPV infection was 17.06%, 28.30%, 36.43% and 30. 3% in women with normal cytology, mild inflammation, moderate inflammation and severe inflammation, respectively. The HPV infection was 27. 60%, 52.30%, 61.31%, 86.11% and 91.25% in women with normal cytology, ASCUS. ASCH. LSIL, HSIL, respectively. According to the grouping of HPV viral load from low to high, the incidence of abnormal TCT were 12.92%、 25.93%、 41.38%、 50.52%、 and 65.74%、 in turn. Conclusions In the women with abnormal TCT result, the more severe of cervical diseases, the more incidence of high risk HPV infection can be detected. HPV viral load is associated with the incidence and the severity of cervical disease.
出处 《中国妇产科临床杂志》 2008年第2期94-96,共3页 Chinese Journal of Clinical Obstetrics and Gynecology
关键词 HPV TCT 宫颈癌前病变 病毒负荷量 HPV TCT precancerous cervical diseases viral load
  • 相关文献

参考文献7

  • 1[1]Manos MM,Kinney WK,Hurley LB,et al.Identifying women with cervical neoplasia:using human papillomavirus DNA testing for equivocal papanicolaou results.JAMA,1999,281:1605-1610.
  • 2[2]Thomas D,Ray RM,Qin Q,et al.Risk factors for progression of squamous cell cervical carcinoma insitu to invasive cervical cancer:result of a multiple study.Cancer Cause Contro,2002,13:683-687.
  • 3赵方辉,马俊飞,乔友林,戎寿德,李凌,章文华.人乳头状瘤病毒DNA载量与子宫颈病变的关系[J].中华流行病学杂志,2004,25(11):921-924. 被引量:48
  • 4李隆玉,乔志强.宫颈癌前病变患者治疗前后HPV病毒负荷量变化的临床分析[J].中华肿瘤防治杂志,2006,13(4):298-300. 被引量:24
  • 5[5]Ordi J,Alonson I,Torne A,et al.Human papillomavirus load in Hybrid Capture Ⅱ assay:Dose increasing the cutoff improve the test? Obstet Gynecol,2006,2:0178-0183.
  • 6[6]Van Duin M,Snijders PJF,Schrijnemakers HFJ,et al.Human papillomavirus 16 load in normal and abnormal cervical scrapes:an indicator of CINⅡ/Ⅲ and viral Clearance.Int J Cancer,2002,98:590-595.
  • 7[7]Swan DC,Tucher RA,Tortolero-Luna G,et al.Human papillomavirus DNA copy number is dependent on grade of cervical disease and HPV type.J Clin Microbiol,1999,37:1030-1034.

二级参考文献11

  • 1Hernandez-Hernandez D M,Ornelas-Bernal L,Guido-Jimenez M,et al.Association between high-risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women[J].Gynecol Oncol,2003,90(2):310-317.
  • 2An H J,Cho N H,Lee S Y,et al.Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method[J].Cancer,2003,97(7):1672-1680.
  • 3Khan M J,Schiffman M,Jeronimo J.et al.Accuracy of human papillomavirus testing in primary screening of cervical neoplasia:results from a multicenter study in India[J].Int J Cancer[J].2005,116(5):830-831.
  • 4Franceschi S,Rajkumar T,Vaccarella S,et al.Human papillomavirus and risk factors for cervical cancer in chennai,india:a case-control study[J].Int J Cancer,2003,107 (1):127-133.
  • 5Lorincz A T,Castle P E,Sherman M E,et al.Viral load of human papillomavirus and risk of CIN Ⅲ or cervical cancer[J].Lancet,2002,360(9328):228-229.
  • 6LoK W,Wong Y F,Chan M K,et al.Prevalence of human papillomavirus in cervical cancer:A multicenter study in china[J].Int J Cancer,2002,100(3):327-331.
  • 7Abba M C,Mouron S A,Gomez M A,et al.Association of human papillomavirus viral load with HPV16 and highgrade intraepithelial lesion[J].Int J Gynecol Cancer,2003,13(2):154-158.
  • 8Nygard J F,Sauer T,Skjeldestad F E,et al.CIN 2/3 and cervical cancer after an ASCUS pap smear.A 7-year,prospective study of the Norwegian population-based,coordinated screening program[J].Acta Cytol,2003,47(6):991-1000.
  • 9Dalstein V,Riethmuller D,Pretet J L,et al.Persistence and load of high-risk HPV are predictors for development of highgrade cervical lesions:A longitudinal French cohort study[J].Int J Cancer,2003,106(3):396-403.
  • 10Houfflin Debarge V,Collinet P,Vinatier D,et al.Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions[J].Gynecol Oncol,2003,90 (3):587-592.

共引文献68

同被引文献269

引证文献34

二级引证文献249

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部